Results 51 to 60 of about 72,174 (202)

Cycle control with an extended-regimen oral contraceptive combining levonorgestrel and ethinyl estradiol that includes continuous low-dose ethinyl estradiol instead of the traditional hormone-free interval [PDF]

open access: yes, 2017
To evaluate scheduled and unscheduled bleeding and spotting over 1 year of treatment with 91-day extended-regimen combined oral contraception (COC) providing continuous low-dose ethinyl estradiol (EE) in place of the traditional 7-day hormone-free ...
Lobo Abascal, Paloma   +8 more
core   +1 more source

Advances in contraception: vaginal contraceptive rings

open access: yesTherapeutic Advances in Reproductive Health, 2023
The vaginal contraceptive ring is very effective and user dependent. In this article, we will discuss the different types of vaginal contraceptive rings, namely, the etonogestrel/ethinyl estradiol (ENG/EE) ring (NuvaRing, Merck, Rahway, NJ, USA) and the ...
Sara Al-Haddad   +2 more
doaj   +1 more source

Structural Diversity of Ethinyl Estradiol Solvates

open access: yesCrystal Growth & Design, 2008
The (pseudo)polymorphism of ethinyl estradiol was investigated via extensive crystallization experiments. Four new crystal structures of ethinyl estradiol solvates that resulted from this study are presented. They contain dioxane, nitromethane, ethanol, or dimethylformamide.
Guguta, C.   +3 more
openaire   +2 more sources

PharmVar GeneFocus: CYP1A2—Clinical Impact, Genetic Variation, and Updated Nomenclature

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 313-323, August 2026.
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human CYP1A2 gene. CYP1A2 plays a crucial role in the biotransformation of several commonly used drugs, including antipsychotics, antidepressants, anxiolytics, and methylxanthines.
Katalin Monostory   +13 more
wiley   +1 more source

Pills-related severe adverse events: A case report in Taiwan

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2016
Objective: To review and evaluate the potential adverse effects of these oral contraceptives (OCP) to overweight women. Case Report: A 19-year-old college student, with a body mass index (BMI) of 35.2 kg/m2, who received 2 months of OCP containing ...
Ching-Hui Chen   +4 more
doaj   +1 more source

Evaluation of a Point‐of‐Care Viscoelastic Coagulation Monitor (VCM Vet) and Thromboelastography (TEG) in Bonobos (Pan paniscus)

open access: yesJournal of Medical Primatology, Volume 55, Issue 4, August 2026.
ABSTRACT Introduction Bonobos (Pan paniscus) are endangered and uncommon in managed care. Prothrombotic and hypofibrinolytic states are encountered with cardiovascular disease, ischemic stroke, and neoplasia. Materials and Methods Twelve bonobos from one institution were evaluated during anesthetized exams.
Megan M. Roeder   +7 more
wiley   +1 more source

Ovarian hormones modulate multidrug resistance transporters in the ovary

open access: yesContraception and Reproductive Medicine, 2018
Background Multidrug resistance transporters (MDRs) are transmembrane proteins that efflux metabolites and xenobiotics. They are highly conserved in sequence and function in bacteria and eukaryotes and play important roles in cellular homeostasis, as ...
Lynae M Brayboy   +4 more
doaj   +1 more source

Metroplasty before IVF in women with a T‐shaped uterus: A clinical challenge

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 174, Issue 1, Page 86-95, July 2026.
Abstract A T‐shaped uterus is a uterine malformation, which can be either congenital or acquired, potentially impairing fertility and increasing the risk of miscarriage. Diagnosis primarily relies on three‐dimensional ultrasound and hysteroscopy. Hysteroscopic metroplasty is the standard surgical intervention aimed at restoring normal uterine anatomy ...
Fabio Barra   +9 more
wiley   +1 more source

Prescription trends for combined oral contraceptives and thromboembolism incidence in Japan before and after public awareness events in 2013–2015

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 174, Issue 1, Page 299-308, July 2026.
Abstract Objective Combined oral contraceptives (COCs) for dysmenorrhea management have been covered by the Japanese universal health insurance system since 2008. Several public awareness events regarding COC prescriptions for dysmenorrhea were implemented between 2013 and 2015, including media reports on COC‐related fatalities in 2013, drug safety ...
Risa Ishida   +8 more
wiley   +1 more source

Association between the use of oral contraceptives and the occurrence of systemic hypertension: A systematic review with statistical comparison between randomized clinical trial interventions

open access: yesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology: X
Introduction: In the WHO eligibility criteria, there is agreement that hypertensive women taking Oral Contraceptive Hormonal Combined (OCHC) may be at increased risk of cardiovascular disease.
Ingrid Soares de Souza   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy